Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | +0.40% | +3.66% | -42.59% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.59% | 385M | |
+9.13% | 114B | |
+11.47% | 104B | |
-13.99% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.72% | 17.89B | |
+7.76% | 14.28B | |
+34.89% | 12.55B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Morgan Stanley Downgrades Talaris Therapeutics to Equalweight From Overweight; Price Target is $8